STAT

Opinion: Pharma should take a tip from the chemical industry to stem the outrage over drug pricing

The pharma industry needs to double down on direct community engagement and be far more transparent about drug pricing.
Americans aren't happy about the cost of drugs. Here New York City activists protest the high price of EpiPens. Source: Photo by Drew Angerer/Getty Images

No one seems to know what President Trump will say when (or if — he has postponed before) he addresses the nation this week on drug pricing. But the content doesn’t matter nearly as much as the implications. The mere fact that drug pricing has become such a populist issue that this president is devoting a policy speech to it will almost certainly roil markets and raise the collective blood pressure of pharmaceutical company CEOs.

When it comes to drug prices, an increasingly vocal majority of Americans now, for example, showed that only 13 percent of patients thought pharma companies effectively explain pricing policies.

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readPsychology
It’s Not Just Bosses Who Harass Health Workers: Hospitals Start Addressing Patients’ ‘Egregious’ Behavior
There's growing awareness that it’s not just bosses and colleagues who sexually harass health care workers. Often, it’s the patients who are doing the harassing.
STAT5 min readPolitics
Opinion: Wider Use Of Assisted Outpatient Treatment Could Help Individuals With Mental Illness
Many states still rely on laws that require individuals to become dangerous to themselves or others before they can be treated without their consent. We need laws that that prevent…
STAT9 min readWellness
‘The Switch’ Was Supposed To Be A Major Step Toward Eradicating Polio. Now It’s A Quandary
A change in polio vaccination policies was supposed to put the world on a better footing to finally eliminate a global scourge. It's gotten complicated.